Development of cost-effective real-time PCR test: To detect a wide range of HBV DNA concentrations in the western amazon region of Brazil

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  De Oliveira Dos Santos, Alcione ^a,b,c   Souza, Luan Felipo Botelho ^a,b,c   Borzacov, Lourdes Maria ^b   Villalobos Salcedo, Juan Miguel ^a,b,c   Vieira, Deusilene Souza ^a,b,c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Centro de Medicina Tropical de Rondônia   (Brazil)

^c UNIVERSIDADE FEDERAL DE RONDÔNIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; BRAZIL; CALIBRATION; COST; COST EFFECTIVENESS ANALYSIS; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SEROCONVERSION; VIRUS LOAD;

BRAZIL; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84893336416     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-16     Document Type: Article

References (33)

1. "Hepatitis B virus infection-natural history and clinical consequences" Ganem D, Prince AM, N Engl J Med 2004 350 1118 1129 10.1056/NEJMra031087 15014185 (Pubitemid 38298992)
2. "Variability in the precore and core promoter regions of HBV strais in Morocco: characterization and impact on liver diasease progression. Kitab B, Essaid EL Feydi A, Afifi R, Trepo C, Benazzouz M, Essamri W, Zoulim F, Chemin I, Alj HS, et al. PLoS One 2012 7 42891 10.1371/journal.pone.0042891 22905181
3. Immune control of hepatitis B virus. Bauer T, Sprinzl M, Protzer U, Dig Dis 2011 29 423 433 21894014
4. "Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy" Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, Transfusion 2004 44 1332 1339 10.1111/j.1537-2995.2004.04055.x 15318857 (Pubitemid 39129246)
5. "Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor" Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R, J Clin Virol 2007 40 255 258 10.1016/j.jcv.2007.08.003 17869170 (Pubitemid 47552920)
6. "Occult hepatitis B virus in liver tissue of individuals without hepatic disease" Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, Di Vita G, Scisca C, Squadrito G, et al. J Hepatol 2008 48 743 746 10.1016/j.jhep.2008.01.023 18314221
7. Validation and standardisation of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. Saldanha J, J Clin Virol 2001 20 7 13 10.1016/S1386-6532(00)00149-9 11163577 (Pubitemid 32037145)
8. "Transfusion-transmitted hepatitis B virus infection" Candotti D, Allain JP, J Hepatol 2009 51 798 809 10.1016/j.jhep.2009.05.020 19615780
9. "Emerging homogeneous DNA-based technologies in the clinical laboratory" Foy CA, Parkes HC, Clin Chem 2001 47 990 1000 11375283 (Pubitemid 32493583)
10. "Hepatitis B vaccination of health care workers in Saudi Arabia" Arya SC, Agarwal N, Am J Infect Control 2005 33 613 614 author reply 612-613 10.1016/j.ajic.2005.05.022 16330313 (Pubitemid 41745208)
11. "Contamination with PCR detectable virus in a virus isolation quality assurance panel" Gunson RN, Abraham E, Carman WF, J Virol Methods 2006 137 150 151 10.1016/j.jviromet.2006.05.018 16860403 (Pubitemid 44189500)
12. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. Pas SD, Fries E, De Man RA, Osterhaus AD, Niesters HG, J Clin Microbiol 2000 38 2897 2901 10921947 (Pubitemid 30640570)
13. "Beware! Uncle Sam has your DNA: legal fallout from its use and misuse in the U.S" Weiss MJ, Ethics Inf Technol 2004 6 55 63 16969961
14. "Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay" Ronsin C, Pillet A, Bali C, Denoyel GA, J Clin Microbiol 2006 44 1390 1399 10.1128/JCM.44.4.1390-1399.2006 16597867
15. "The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection" Berger A, Preiser W, Doerr HW, J Clin Virol 2006 20 23 30
16. "Real-time PCR in virology" Mackay IM, Arden KE, Nitsche A, Nucleic Acids Res 2002 30 1292 1305 10.1093/nar/30.6.1292 11884626 (Pubitemid 34679706)
17. Avoiding false positives with PCR. Kwok S, Higuchi R, Nature 1989 339 237 238 10.1038/339237a0 2716852
18. "Kinetics of hepatitis B virus reactivation after chemotherapy: more questions than answers" Liu CJ, Kao JH, Chen DS, Gastroenterology 2006 131 1656 1657 17101335
19. "Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India" Panigrahi R, Majumder S, Gooptu M, Biswas A, Datta S, Chandra PK, Banerjee A, Chakrabarti S, Bandopadhyay D, et al. Ann Hepatol 2012 11 870 875 23109450
20. "Occult hepatitis B virus infection: implications in transfusion" Allain JP, Vox Sang 2004 86 83 91 10.1111/j.0042-9007.2004. 00406.x 15023176 (Pubitemid 38436885)
21. "Blood screening for HBV DNA" Fang CT, J Clin Virol 2006 36 1 30 32
22. "Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study" Keyvani H, Agah S, Kabir A, Alavian SM, Ann Hepatol 2013 12 213 219 23396732
23. "Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India" Chakrabarti S, Bandopadhyay D, Ann Hepatol 2012 11 870 875 23109450
24. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Paraskevis D, Beloukas A, Haida C, Katsoulidou A, Moschidis Z, Hatzitheodorou H, Varaklioti A, Sypsa V, Hatzakis A, Virol J 2010 7 57 10.1186/1743-422X-7-57 20226057
25. Development and assessment of a novel real-time PCR assay for quantitation of HBV DNA. Paraskevis D, Haida C, Tassopoulos N, Raptopoulou M, Tsantoulas D, Papachristou H, Sypsa V, Hatzakis A, J Virol Methods 2012 103 201 212
26. "Quantitation of hepatitis B virus DNA by real-time PCR using internal amplification control and dual TaqMan MGB probes" Lole KS, Arankalle VA, J Virol Methods 2006 135 83 90 10.1016/j.jviromet.2006.02.004 16551481 (Pubitemid 43728844)
27. "Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays" Pawlotsky JM, Bastie A, Hezode C, Lonjon I, Darthuy F, Remire J, Dhumeaux D, J Virol Methods 2000 85 11 21 10.1016/S0166-0934(99)00149-4 10716334 (Pubitemid 30068578)
28. "Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test" Noborg U, Gusdal A, Pisa EK, Hedrum A, Lindh M, J Clin Microbiol 1999 37 2793 2797 10449454 (Pubitemid 29391889)
29. HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Kanemitsu K, Nishioka K, Vox Sang 2005 88 77 86 10.1111/j.1423-0410.2005.00602.x 15720604 (Pubitemid 40362922)
30. "A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT" Leung VK, Lee CK, Chau TN, Cheung WI, Lo FH, Lai KB, Lin CK, Transfus Med 2010 20 276 277 10.1111/j.1365-3148.2010.00997.x 20149156
31. Significant background rates of HBV and HCV infections in patients and risks of blood transfusion from donors with low anti-HBc titres or high anti-HBc titres with high anti-HBs titres in Japan: a prospective, individual NAT study of transfusion-transmitted HBV, HCV and HIV infections. Tani Y, Aso H, Matsukura H, Tadokoro K, Tamori A, Nishiguchi S, Yoshizawa H, Shibata H, Vox Sang 2012 102 285 293 10.1111/j.1423-0410.2011.01561.x 22082342
32. An improved nat assay with enhanced sensitivity for hbv for donor blood screening. Chatterjee K, J Lab Physicians 2012 4 127 23436970
33. "Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. Liu CJ, Chen DS, Chen PJ, J Clin Virol 2006 36 33 44